Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/12835
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVLAYEN, Annemie-
dc.date.accessioned2011-12-19T09:34:48Z-
dc.date.available2011-12-19T09:34:48Z-
dc.date.issued2011-
dc.identifier.citationJournal of Patient Safety, 7(3), p. 165-168-
dc.identifier.urihttp://hdl.handle.net/1942/12835-
dc.description.abstractObjective: This study aimed to evaluate different shortcuts of Healthcare Failure Mode and Effects Analysis (HFMEA) in a radiotherapy setting. Design: A 2 2 study design was set up, in which 4 similar groups analyzed separately the possible risks of the same process by using different versions of HFMEA. Setting: In the Maastricht Radiation Oncology clinic, a radiotherapy institute in the Netherlands, treatment of cancer patients is organized within 3 different units, each focusing on a specific area (thorax, abdomen, and neck-head). The institute plans to treat all radiation areas in one generalized unit (Linac-pool). Participants: All 4 teams were composed of 3 radiation technologists (1 from each working unit), 1 manager radiation technologist, and 1 facilitator. Interventions: Prospective risk analyses were completed in parallel within 1 month. Main Outcome Measures: Time investment and cost data on the different steps of the HFMEAs were registered from the organizations’ perspective. Each team suggested a number of corrective actions for the Linac-pool. The quality and feasibility of the proposed actions were assessed by an expert panel (managers and safety staff ). Results: The HFMEA analyses resulted in direct costs varying from 1028.6 to 1701.6 euros. In total, the expert panel assessed 86 corrective actions, of which 43 (50%) were relevant to implement before the start of the Linac-pool. Many of these actions related to the compliance, control, and education of standard operating procedures in daily practice of radiotherapy. Conclusions: On the basis of the results of this case study, it seems feasible to develop less time- and cost-consuming versions of HFMEA, which would increase even more the added value of prospective risk analysis tools for health care organizations.-
dc.description.sponsorshipLimburg Sterk Merk-
dc.language.isoen-
dc.subject.other'risk management', 'safety management', 'risk assessment', 'costs and cost analysis', 'Failure Mode and Effects Analysis'-
dc.titleEvaluation of time and cost saving modifications of HFMEA: an experimental approach in radiotherapy-
dc.typeJournal Contribution-
dc.identifier.epage168-
dc.identifier.issue3-
dc.identifier.spage165-
dc.identifier.volume7-
local.bibliographicCitation.jcatA2-
dc.relation.references1. Vincent C. Patient Safety: Elsevier Churchill Livingstone; 2006. 2. FMEA Info Center. Available from: http://www.fmeainfocentre.com. 3. Marx DA, Slonim AD. Assessing patient safety risk before the injury occurs: an introduction to sociotechnical probabilistic risk modelling in health care. Qual Saf Health Care. 2003 Dec;12 Suppl 2:ii33-8. 4. U.S. Department of Defense, Washington DC. MIL-STD-1629A: Procedures for Performing a Failure Mode Effects and Criticality Analysis.14 November, 1980. 5. National Center for Patient Safety. Available from: http://www.va.gov/ncps. 6. National Advisory Committee on Microbiological Criteria for Foods. Hazard Analysis and Critical Control Point Principles and Application Guidelines. August 14, 1997; Available from: http://www.fda.gov/Food/FoodSafety/HazardAnalysisCriticalControlPointsHACCP/HACCPPrinciplesApplicationGuidelines/default.htm. 7. DeRosier J, Stalhandske E, Bagian JP, et al. Using health care Failure Mode and Effect Analysis: the VA National Center for Patient Safety's prospective risk analysis system. Jt Comm J Qual Improv. 2002 May;28(5):248-67, 09. 8. Joint Commission Resources I. Failure Mode and Effects Analysis in Health Care: Proactive Risk Reduction. Third edition Oakbrook, IL.July 2010. 9. (ASHRM). ASfHCRM. Strategies and Tips for Maximizing Failure Mode and Effects Analysis in Your Organization. White paper. July 2002. 10. Apkon M, Leonard J, Probst L, et al. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care. 2004 Aug;13(4):265-71. 11. Ford EC, Gaudette R, Myers L, et al. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):852-8. 12. Shebl NA, Franklin BD, Barber N. Is failure mode and effect analysis reliable? J Patient Saf. 2009 Jun;5(2):86-94. 13. Nickerson T, Jenkins M, Greenall J. Using ISMP Canada's framework for failure mode and effects analysis: a tale of two FMEAs. Healthc Q. 2008;11(3 Spec No.):40-6. 14. Esmail R, Cummings C, Dersch D, et al. Using Healthcare Failure Mode and Effect Analysis tool to review the process of ordering and administrating potassium chloride and potassium phosphate. Healthc Q. 2005;8 Spec No:73-80. 15. Gilchrist M, Franklin BD, Patel JP. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother. 2008 Jul;62(1):177-83. 16. Moyer VA, Singh H, Finkel KL, et al. Transitions from neonatal intensive care unit to ambulatory care: description and evaluation of the proactive risk assessment process. Qual Saf Health Care. 2010 Oct;19 Suppl 3:i26-30. 17. Wetterneck TB, Skibinski KA, Roberts TL, et al. Using failure mode and effects analysis to plan implementation of smart i.v. pump technology. Am J Health Syst Pharm. 2006 Aug 15;63(16):1528-38. 18. Paparella S. Failure mode and effects analysis: a useful tool for risk identification and injury prevention. J Emerg Nurs. 2007 Aug;33(4):367-71. 19. Bonnabry P, Cingria L, Ackermann M, et al. Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care. 2006 Feb;18(1):9-16. 20. Linkin DR, Sausman C, Santos L, et al. Applicability of Healthcare Failure Mode and Effects Analysis to healthcare epidemiology: evaluation of the sterilization and use of surgical instruments. Clin Infect Dis. 2005 Oct 1;41(7):1014-9. 21. van Tilburg CM, Leistikow IP, Rademaker CM, et al. Health Care Failure Mode and Effect Analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual Saf Health Care. 2006 Feb;15(1):58-63. 22. Ashley L, Armitage G, Neary M, et al. A practical guide to failure mode and effects analysis in health care: making the most of the team and its meetings. Jt Comm J Qual Patient Saf. 2010 Aug;36(8):351-8. 23. Failure mode and effects analysis. A hands-on guide for healthcare facilities. Health Devices. 2004 Jul;33(7):233-43. 24. Habraken MM, Van der Schaaf TW, Leistikow IP, et al. Prospective risk analysis of health care processes: a systematic evaluation of the use of HFMEA in Dutch health care. Ergonomics. 2009 Jul;52(7):809-19. 25. Fukuda H, Imanaka Y, Hirose M, et al. Factors associated with system-level activities for patient safety and infection control. Health Policy. 2009 Jan;89(1):26-36.-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA2-
dc.identifier.doi10.1097/PTS.0b013e31822b07ee-
item.fullcitationVLAYEN, Annemie (2011) Evaluation of time and cost saving modifications of HFMEA: an experimental approach in radiotherapy. In: Journal of Patient Safety, 7(3), p. 165-168.-
item.fulltextNo Fulltext-
item.contributorVLAYEN, Annemie-
item.accessRightsClosed Access-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

10
checked on Sep 6, 2020

WEB OF SCIENCETM
Citations

11
checked on Sep 28, 2024

Page view(s)

46
checked on Aug 6, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.